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Abstract
Background: Most research on failure leading to revision total hip arthroplasty (THA) is reported from single centers. We
searched PubMed between January 2000 and August 2010 to identify population- or community-based studies evaluating
ten-year revision risks. We report ten-year revision risk using the Kaplan-Meier method, stratifying by age and fixation
technique.
Results: Thirteen papers met the inclusion criteria. Cemented prostheses had Kaplan-Meier estimates of revision-free
implant survival of ten years ranging from 88% to 95%; uncemented prostheses had Kaplan-Meier estimates from 80% to
85%. Estimates ranged from 72% to 86% in patients less than 60 years old and from 90 to 96% in older patients.
Conclusion: Datareportedfrom national registries suggest revisionrisks of 5 to 20%tenyears followingprimary THA. Revision
risks are lower in older THA recipients. Uncemented implants may have higher ten-year rates of revision, regardless of age.
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Introduction
Total hip arthroplasty (THA) is an efficacious and cost-effective
intervention for reducing pain and improving function in patients
with advanced hip arthritis [1,2,3,4]. Long-term studies of THA
recipients have generally shown that the probability of surviving
without undergoing a revision THA exceeds 90% at ten years and
80% at 25 years [1,5,6,7,8,9]. However, most of these reports have
been from single referral centers or single surgeons, and most refer
to only one type of implant [1,7,9,10,11]. Large national studies,
especially population-based studies, provide a better framework for
estimating implant survival rates that can more readily be
generalized to the majority of patients receiving THA.
While randomized controlled trials are still considered the gold
standard for evaluating medical outcomes, trials are both cost-
prohibitive and impractical for evaluating the risk of long-term
THA revision [2]. National or regional joint replacement registries
have the potential to fill this gap in our understanding of long-term
THA outcomes. Primary goals of registries include providing data
on utilization patterns of total joint replacement and identifying
risk factors for poor outcomes and poorly performing devices [2].
The national hip arthroplasty registries from Finland (origination
date: 1980), Norway (1987), and Sweden (1979) have been crucial
in defining the risks of subsequent revision surgery. By providing
feedback to the healthcare community and identifying specific
implants with poor results, the registries have also helped to
improve the outcomes of THA [12]. Over the past few years,
several additional countries have begun national joint registries:
Denmark (1994), New Zealand (1997), Hungary (1998), Australia
(1998), and Canada (2001).
The national THA registries have produced substantial research
on the outcomes and failures of hip arthroplasty from individual
countries. However, to our knowledge, the literature on the long-
term revision rates following THA in national samples has not
been reviewed systematically. Revision data, particularly from
national samples, are needed to guide discussions of implant
longevity and the risk of revision for elective THA. Health
policymakers also need access to such data to anticipate revision
volume and associated costs. The goal of this review is to
summarize published data on primary THA revision rates over ten
years in large national community-based or population-based
studies. Additionally, we examine the influence of patient age and
prosthesis fixation technique on THA revision rates.
Methods
Note: The protocol for this trial and supporting CONSORT checklist are
available as supporting information; see PRISMA Checklist S1 and PRISMA
Flow Diagram S1.
Search Strategy
We conducted a PubMed search to identify studies written in
English that were published between January 2000 and August
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e135202010. We did not include articles published prior to 2000 in order
to reduce heterogeneity in biomaterials and process of care. We
restricted the review to articles published in the peer-reviewed
literature to ensure a high level of rigor and quality. We used
PubMed hip arthroplasty MeSH Term keywords in combination
with search terms relating to revision rates and prosthesis survival
and failure. Our verbatim search query, performed August 10,
2010, was:
(‘‘Arthroplasty, Replacement, Hip/methods’’[MAJR] OR ‘‘Arthro-
plasty, Replacement, Hip/statistics and numerical data’’[MAJR])
AND (‘‘revision rates’’ OR ‘‘revision rate’’ OR ‘‘rates of revision’’ OR
‘‘rate of revision’’ OR ‘‘prosthesis failure’’ OR ‘‘prosthesis survival’’)
We screened the title and abstract of each article identified for
relevance to this literature review. To be included for further
review, the studies had to discuss primary hip prosthesis failure
leading to revision, provide long-term follow-up, and represent
either population- or community-based samples. Single surgeon
series, single hospital series, and collaborations between referral
centers were excluded based on review of abstracts. Studies
reporting only on specific failure mechanisms (e.g. dislocation or
infection) were excluded, as were studies focused exclusively on
either stem or cup failure (as opposed to failure of any component).
For abstracts that passed this screening, the full length articles were
retrieved and reviewed.
To ensure comparability of articles, minimize bias due to
truncated follow-up, and incorporate the methods used in the
majority of papers reporting prosthesis survival, we chose ten-year
revision-free survival estimated by the Kaplan-Meier method as
the primary outcome for our review. A key advantage of the
Kaplan-Meier method is that it accounts for all persons who were
lost to follow-up or died. We excluded studies that did not report
the Kaplan-Meier ten-year survivorship of the prostheses (with
survivorship defined as the patient surviving without undergoing
revision of the THA).
Data Extraction and Analysis
We abstracted the following information from each eligible
article: the number of patients who had had a primary THA, the
calendar years during which the primary THAs were performed,
the years during which the cohort was followed, the proportion of
patients with osteoarthritis (OA), the definition of revision, the type
of fixation method (cemented, uncemented, hybrid or not
specified), the number of patients at risk at ten years, and the
Kaplan-Meier based probability of revision-free survival at ten
years. Additionally, we abstracted the age of the patients and
whether the papers reported analyses for certain age brackets. The
reports differed in their classification of ‘‘younger’’ patients.
‘‘Younger’’ denotes age less than 60 in one (Norwegian) registry
and less than 55 in two (Finnish and Swedish) registries. Two
authors abstracted each of the articles included in the review to
ensure reliability. Any discrepancies were resolved through
discussion with the senior author.
The principal outcome variable for this analysis was the
Kaplan-Meier probability of revision-free implant survival at ten
years. Some studies provided this parameter and others provided
Kaplan-Meier plots from which we estimated the revision-free
survival at ten years graphically. Two Swedish studies provided
nine-year Kaplan-Meier estimates [12,13] and one Norwegian
study provided eight-year estimates [14]. We transformed these to
Kaplan-Meier ten-year estimates by assuming a constant annual
risk of revision.
In general, studies reported on revision for any reason. Some of
the Swedish [12,13] and Finnish [15] data report revision for
aseptic loosening only. We note these instances in the text, tables
and figures.
We used evidence tables and graphical techniques to describe
the THA revision risks across national and regional registries and
to examine revision risks in relevant subgroups defined by age and
fixation technique (cemented vs. uncemented vs. hybrid). In
circumstances where Kaplan-Meier ten-year revision-free survival
values were given for subgroups defined by fixation status and age
category, we derived summary estimates for fixation groups and
for age groups by calculating weighted averages of Kaplan-Meier
estimates across the relevant subgroups, with weights proportional
to the number of patients in each subgroup.
The funding sources for this study had no role in design, analysis
or reporting of results.
Results
Results of Search
The results of the search for papers on revision of primary THA
in national samples are shown in Figure 1. Thirty-seven abstracts
were identified. Of these, eighteen were excluded from further
consideration because they failed to address hip prosthesis survival
(1 abstract), did not rely on population- or community-based
samples (8), focused on specific causes of revision (1) or because
they provided incidence rates of the primary THA rather than
revision rates (8). Nineteen abstracts were eligible for further
analysis; these papers were retrieved and reviewed. Of these, six
were excluded because the samples were not population- or
community-based. Thirteen papers were used as a basis for the
current review: six from the Finnish Arthroplasty Register
[8,15,16,17,18,19], three from the Swedish Total Hip Replace-
ment Register [12,13,20], three from the Norwegian Arthroplasty
Register [14,21,22], and one from the Trent Regional Arthro-
plasty Study (TRAS) in England [23] (see Table 1). The Swedish,
Norwegian, Finnish, and Trent Registers are described in
Appendix S1 (see supporting information).
Revision Risk
Fixation. Our findings suggest that cemented implants have
greater longevity when compared broadly to uncemented implants
(Figure 2). Cemented prostheses had ten-year Kaplan-Meier
estimates of revision-free survival ranging between 88% (95% CI
not provided) in Finland to 95% (95% CI: 94.1, 96.3) in Norway.
Uncemented prostheses had higher revision risks across the
registers, with Kaplan-Meier ten-year revision-free survival
estimates ranging from 80% in Finland (95% CI not provided)
to 85% (95% CI: 84, 87) in Sweden. Hybrid prosthesis revision
risks were only reported in the Swedish Register, precluding
comparison of hybrid prosthesis survival data across countries. In
Sweden, hybrid prosthesis survival with revision for aseptic
loosening only as the endpoint had a 10-year survival of 92.7%
(95% CI: 90.1, 95.4). Osteoarthritis was the only diagnosis
included in these estimates of revision risk by fixation, with the
exception of the English sample, which was 87% OA, and the
uncemented Norwegian sample which ranged from 31 to 71%
OA.
Age. The Kaplan-Meier ten-year revision-free survival
estimates for younger patients ranged from 72% (95% CI: 67,
76) in Finland to 86% (95% CI: 84.5, 88.2) in Sweden (Figure 3).
Revision risk was lower in older patients, with Kaplan-Meier ten-
year revision-free survival estimates ranging from 90% (95% CI:
89, 91) in Finland to 97% (95% CI: 96.3, 97) in Sweden. The
Revision Rates of Primary THA
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estimates were inclusive of all fixation methods (e.g. cemented,
uncemented) and types of prostheses. The Norwegian reports
excluded all diagnoses other than OA, while the Swedish sample
was 75% OA and the Finnish sample was 78% OA.
Fixation and Age. To address the possibility that the main
effects for fixation are confounded by age, we examined estimates
of prosthesis revision risk in subgroups defined by fixation and age.
These analyses are shown in Table 2. In younger and in older
patients, cemented implants had lower revision risks than
uncemented implants. Among both cemented and uncemented
implants, revision risk was lower in older than in younger patients.
The endpoint for these estimates was revision for any reason,
except in the Swedish data, which report revision due to aseptic
loosening only.
Discussion
Long-term clinical results of THA have been well-documented
in the literature. However, the vast majority of studies report
findings from individual referral centers. The comprehensive
Scandinavian Registers have reported on prosthesis revision rates
Table 1. Overview of papers included in the review.
Paper source (Citation #)N
Years of
operation
Years of
follow-up AR/N
Definition of survival
endpoint Definition of Revision Country
Allami et al (2006) Outcome
of Charnley total hip
replacement (23)
1,198 (C) 1990 1990–2002 N/A Revision for any reason Removal of original
components
England
Eskelinen et al (2006) Uncemented
Total Hip Arthroplasty (16)
1410 (U) 1980–2003 1980–2005* 482/1410(.34) Revision for any reason Removal or exchange
of any component
Finland
Maleka et al (2008) Cemented
total hip replacement for
primary osteoarthritis (8)
26347(C) 1980–2005 1980–2005* 10645/26347(.40) Revision for any reason Removal or exchange of the
femoral head, liner or the
whole implant
Finland
Makela et al (2008) THA for
primary osteoarthritis in patients
fifty-five years or older (17)
34296 (C)
12888 (U)
3784 (H)
1980–2004
1985–2004
1988–2004
1980–2005
1985–2004
1988–2004
10343/34296 (.30)
2750/12888 (.21)
344/3784 (.09)
Revision for any reason Exchange or removal of the
cup and/or stem or
exchange of the liner
Finland
Makela (2010) Cementless THA
for primary osteoarthritis in
patients aged 55 years and
older (15)
9,549 (C)
10,310 (U)
1980–2005 1980–2005 4447/9549 (.47)
2610/10310 (.25)
Revision due to aseptic
loosening only
Surgical removal or exchange
of the whole or part of the
implant
Finland
Ogino et al (2008) Total Hip
Replacement in Patients eighty
years of age and older (18)
5047 (C)
399 (U)
729 (H)
1980–2004 1980–2004 N/A Revision for any reason Removal, exchange, or
reimplantation of one, or
both, of the prosthetic
component
Finland
Puolakka et al (2001) The
Finnish Arthroplasty
Register (19)
4,609 (C)
5,519 (U)
1990–1994 1990–2000 N/A Revision for any reason Exchange or removal of
part of a component,
or the whole implant
Finland
Espehaug (2009) 18 years of
results with cemented primary
hip prostheses in the Norwegian
ArthroplastyRegister (14)
24728 (C)
37577 (C)
1987–1997
1998–2007
1987–2007
1998–2007
14622/24728 (.59)
4298/37577 (0.11)
Revision for any reason Surgical removal or exchange
of the whole or part of the
implant
Norway
Furnes et al (2001), Hip disease
and the prognosis of total hip
replacements (21)
37215 (US)
11225 (C)
1987–1999 1987–1999 2384/37215 (.06)
703/11225 (.06)
Revision for any reason Removal or exchange of
a part of, or the whole
implant
Norway
Hallan et al (2007) Medium-
and long-term performance of
11,516 uncemented primary
femoral stems from the
Norwegian arthroplasty
register (22)
8,444 (U) 1987–2005 1987–2006 N/A Revision for any reason Revision of any component
(acetabular shell, liner
or stem)
Norway
Hailer (2010) Uncemented and
cemented primary THA in the
Swedish Hip Arthroplasty Register
(20)
161,413 (C)
8,953 (U)
1992–2007 1992–2007 N/A Revision for any reason Exchange or removal of
any part of the cup or
stem, or the entire implant
Sweden
Herberts and Malchau (2000),
Long-term registration has
improved the quality of hip
replacement (13)
65,689 (C)
2645 (U)
1988–1997 1988–1997 N/A Revision due to aseptic
loosening only
Exchange or removal of one
or both components of the
prosthesis; Exchange of a
liner or head component
Sweden
Malchau et al (2000), The
Swedish THR Register (12)
2588 (CY)
56820(CO)
1004 (UY)
1083 (HY)
1992–2000
1992–2000
1992–2000
1992–2000
1992–2001*
1992–2001*
1992–2001*
1992–2001*
N/A Revision due to aseptic
loosening only
Exchange or removal of
one or both components,
or the implant
Sweden
C= cemented; CO= cemented old; CY=cemented young; U= uncemented; UY= uncemented young; H= hybrid; HY= hybrid young; US= unspecified;
AR/N= No. at risk at 10 yr/No. of primary operations;
*Estimate because years of follow-up were not given.
doi:10.1371/journal.pone.0013520.t001
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revision risk in large, national populations. However, to our
knowledge, there has not been a systematic literature review of
published articles describing THA survival rates from these large
national or regional registries. We have summarized and
compared findings from national and regional studies to describe
the ten-year prosthesis survival following primary THA. We
excluded papers with follow-up shorter than ten years, which
prevented us from including data from the US Medicare
population and the Danish Register. We did include three papers
from Norway and Sweden with reported Kaplan-Meier rates of
eight and nine years, respectively, from which we were able to
extrapolate ten-year survival data, as described in the Methods
section.
The findings suggest that both implant fixation and patient age
influence prosthesis revision rates in large population- or
community-based samples. Older patients with hip implants had
revision-free implant survival rates that exceeded 90% at ten years,
while the rates for younger patients ranged from 72 to 86%.
Cemented implants had lower revision risk than uncemented
implants in both younger and older patients. It is possible,
however, that this finding is due to residual confounding by age
and activity level, with uncemented implants used in younger,
more active individuals.
Referral centers have documented greater than 90% revision-
free implant survival at ten years, and greater than 80% revision-
free implant survival at 25 years following primary THA [1,5,7,9].
Because of the heterogeneity in patient and hospital factors across
large national and regional samples, it is not surprising to find
somewhat higher revision rates in national registries than at
referral centers. The data provided in the registry studies do not
permit adjustment of revision rates for hospital or surgeon
characteristics, such as procedure volume.
Methodological Challenges
Readers should be cautioned when interpreting implant revision
data. By ten years postoperatively, the number of patients still at
risk for revision THA may be quite small. Thus, revision-free
survival estimates may be based on a minority of the entire sample.
For example, Furnes et al reported that of 37,215 hips replaced in
Norway for OA, inclusive of all ages and prostheses, the Kaplan-
Meier ten-year revision-free implant survival estimate was 88.8%
with revision for any reason as the endpoint. However, only 2,384
hips were still at risk at ten years, which means the K-M 10
estimate is based upon data from just 6% of the original sample.
Patients become censored when they are revised, lost to follow-up
or die, and they are seldom followed long enough to contribute
ten-year survival data. In this example, the mean follow-up time
Figure 2. Kaplan-Meier ten-year hip prosthesis survival by fixation technique. Kaplan-Meier ten-year estimates are presented, stratified by
national register and fixation technique. Circle area is proportional to the sample size. Error bars represent 95% CIs. All estimates use revision for any
reason as the endpoint. Cemented Norway and cemented England are single prosthesis studies, including only Charnley implants. The K-M 10 for
uncemented THA in Norway is the weighted average of nine [21,22] or ten [14] types of implant. All others are inclusive of all prosthesis brands. The
Finnish K-M 10 data were estimated from K-M curves. Estimates are inclusive of all patient ages. 31% to 71% of the uncemented Norwegian sample,
87% of the English sample, and 100% of the remaining registers’ samples were operated on for osteoarthritis. Each study reference is denoted next to
the circle, representing the corresponding manuscript from which the Kaplan-Meier estimates were derived.
doi:10.1371/journal.pone.0013520.g002
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of the K-M 10 estimates, only a fraction of the entire cohort was
eligible to be analyzed [21]. Only six of the thirteen papers
analyzed in this review provided information on the number of
patients eligible for Kaplan-Meier analysis at ten years
[8,14,15,16,17,21]. The proportion of original cohort members
eligible for analysis at ten years in these four studies ranged from
6% to 59% (see Table 1).
Implicit in any discussion of revision rates is the definition of
failure. The papers we analyzed all used revision as the endpoint.
The majority of the papers provided data on revision for any
reason, as well as on revision due specifically to aseptic loosening.
We focused on revision for any reason, relying on this broader
criterion because both patients and policy-makers consider any
revision to be important, irrespective of the specific reason for
prosthesis failure. However, two reports from the Swedish Register
[12,13] and one report from the Finnish Register [15] only
documented revision due to aseptic loosening (see Table 1), and
we have indicated in any figure or table legends whether these
more narrowly defined revision data have been used. Unless
otherwise noted, all reported data compare survival rates in which
the endpoint was revision for any reason.
Revision surgery is an unambiguous endpoint for a failed total
hip replacement. However, revision rates do not capture implants
that have failed clinically but have not been treated surgically. For
example, this criterion would miss patients with painful, loose
prostheses who do not seek medical attention, choose not to have
revision, or are not offered revision because their general health is
too unstable. Revision is a blunt measure that gives no information
on clinical or radiographic outcome or patient satisfaction.
Validation studies on the Swedish Register have indicated that
clinical failure rates at ten years, as defined by radiographic
loosening in combination with the Harris Hip Score and the
Western Ontario and McMaster Osteoarthritis Index (WOMAC),
are at least twice as high as the revision rates reported by the
Register [4,13,24].
As implants and fixation techniques evolve over time, it is
important to consider how changes might influence overall rates of
revision. In Sweden, for example, modern cementing techniques
were introduced in the late 1980s and fully established by the early
1990s. These changes improved the cementing process, and are
acknowledged as among the reasons for a ten-year revision-free
hip prosthesis survival rate of up to 94% [13]. Modern cementing
techniques have only been documented in the Finnish Register
Figure 3. Kaplan-Meier ten-year hip prosthesis survival by age group. Kaplan-Meier ten-year estimates are stratified by register and age
group. Circle area is proportional to the sample size. Error bars represent 95% CIs. Estimates are inclusive of all prosthesis types. The endpoint was
revision for any reason, except for the Swedish studies, where it was revision due to aseptic loosening only. 75% of the Swedish sample, 78% of the
Finnish sample, and 100% of the Norwegian sample were operated on for osteoarthritis. Each study reference is denoted next to the circle,
representing the corresponding manuscript from which the Kaplan-Meier estimates were derived.
doi:10.1371/journal.pone.0013520.g003
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to reduce the influence of such secular changes.
We limited the review to published studies in order to maintain
a consistently high standard of methodological rigor. We
acknowledge, however, that several registries in countries outside
Scandinavia and England offer valuable unpublished data. For
example, although the findings we report from Scandinavian
countries document better prosthesis survival in cemented than in
uncemented designs, data from the Australian Registry suggest
that cemented and uncemented prostheses have similar survival
[25]. The Australian Registry was established in 1998 and its
website provides revision data on cases operated upon from 1999
to 2008. We did not include the Australian data in our formal
analyses because they have not been published in a peer-reviewed
journal. The discrepancy between Scandinavian and Australian
registries in the performance of cemented vs. uncemented
prostheses could reflect differences in control for potential
confounders but may also reflect differences across countries in
technique, materials, or indications.
The Australian data also show higher survival rates overall than
many of the studies we included. Extrapolating from the
Australian Registry’s eight-year prosthesis survival rate of 95.1%
by assuming a constant revision rate yields a ten-year survival rate
of 94.1%, which is considerably higher than many of the survival
rates reported in the Scandinavian Registries (Table 2). The
Australian data reflect a more recent THA prosthesis survival
experience, incorporating primary and revision hip replacements
performed between 1998 and 2008. Similarly, the New Zealand
National Joint Register reports a ten-year survival rate of 93.5%
based on procedures performed between 1999 and 2008 [26].
Thus, the improved survival in the Australian and New Zealand
data as compared with the Scandinavian experience may point to
important secular changes. These observations from the antipo-
dean registries suggest that published registry data may themselves
have important limitations that should be appreciated before
making broad inferences. The discrepancies between these data
sources also urge caution in generalizing the Scandinavian
experience.
Limitations
We acknowledge that these national estimates cannot adjust for
differences between implant groups in factors such as activity level
and weight, which may affect revision risk. It should also be noted
that arthroplasty registers may report OA as the underlying
diagnosis in some patients who in fact have mild developmental
dysplasia [6,27]. Patients with dysplasia may have worse outcomes
following THA than patients with OA, and this difference might
skew the reported survival estimates [6,21]. Additionally, we
recognize the inherent imprecision in estimating K-M 10 revision-
free survival from curves when the actual data were not presented
in tables [18,19]. The potential subjectivity of this approach is
mitigated in part by having two independent abstractors, with any
discrepancies resolved by the senior author.
Conclusion
These methodological challenges and limitations notwithstand-
ing, we summarized ten-year prosthesis revision rates from
international registry-based studies, a task that, to our knowledge,
has not been done before. Our findings suggest that older patients
who live for ten years following total hip arthroplasty experience a
ten-year revision risk of about 10%, while younger patients have a
somewhat greater risk of revision. As failure leading to revision is a
critically important endpoint of THA from the standpoint of
patients, surgeons and policy makers, these data will help anchor
discussions of revision risks among these parties. Uncemented
implants may be associated with greater revision risks in both age
groups, although we cannot exclude confounding by age and
activity level. Studies of implant failure are methodologically
complex and should be accompanied by discussion of the
definition of failure and detailed account of the actual number
of subjects at risk at time points of interest.
Supporting Information
Appendix S1 Description of the Registers surveyed in this study
Found at: doi:10.1371/journal.pone.0013520.s001 (0.05 MB
DOC)
Table 2. Kaplan-Meier ten-year revision-free survival estimates by Fixation, Age and Register.
Fixation type Age group Register N
% K-M
10 95% CI
Years of
operation
Years of
follow-up
Age of
cohort % OA
Cemented Young Sweden 2,588 88.8 (83.7, 92.7) 1992–2000 1992–2001* ,55 75
Old Sweden 56,820 96.2 (95.8, 96.7) 1992–2000 1992–2001* $55 75
Finland 34,296 89.0 (89, 89) 1980–2004 1980–2005 $55 100
Weighted average 93,704 93.5
Uncemented Young Sweden 1,004 94.7 (92.5, 96.9) 1992–2000 1992–2001* ,55 75
Finland** 1,410 77 1980–2003 1980–2005* ,55 100
Weighted average 2,414 84.4
Old Finland‘ 7,145 86.0 (85, 88) 1986–2004 1986–2004 $55 100
Finland‘ 5,743 87.0 (86, 88) 1985–2004 1985–2004 $55 100
Weighted average 12,888 86.4
Hybrid Young Sweden 1,083 92.2 (87.5, 97.1) 1992–2000 1992–2001* ,55 75
Old Finland 3,784 88.0 (86, 90) 1988–2004 1988–2004 $55 100
*Estimate because years of follow-up were not given;
**Comprised from weighted averages of multiple implants;
‘Note, these two studies from Finland involve different prostheses; the patient samples are independent;
Outcome here is revision due only to aseptic loosening for the Swedish Registry and revision for all indications for the other registries.
doi:10.1371/journal.pone.0013520.t002
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Found at: doi:10.1371/journal.pone.0013520.s002 (0.06 MB
DOC)
PRISMA Checklist S1
Found at: doi:10.1371/journal.pone.0013520.s003 (0.08 MB
DOC)
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